Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 4 (2020) Development of a method for calculation of demand for medical personnel in the healthcare of the Russian Federation, using a mathematical model Abstract  similar documents
V. V. Omelyanovsky, T. V. Semenova, D. V. Lukyantseva, D. V. Fedyaev, E. A. Shalaeva
"... for calculation of the demand for medical personnel in the healthcare in the Russian Federation, using ..."
 
Vol 12, No 3 (2019) Approaches to assessing the demand for medical personnel in the Russian Federation Abstract  similar documents
S. N. Tishkina , T. G. Alkhasov , D. V. Lukyantseva , T. P. Bezdenezhnykh 
"... ; especially, the methods of assessing the demand for medical personnel and the arrangements for attracting ..."
 
Vol 18, No 2 (2025) Marketing analysis of the Russian pharmaceutical market for treatment of neovascular age-related macular degeneration Abstract  similar documents
F. V. Gorkavenko, A. B. Goryachev, O. V. Ashikhmina, D. V. Fedyaev, N. V. Ignateva, E. A. Smolyarchuk, A. V. Kirchenko, D. D. Tkachenko, V. I. Brazhnikova
"... , including assessment of the product range, price dynamics, demand and consumption, as well as index analysis ..."
 
Vol 17, No 3 (2024) Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences Abstract  similar documents
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov
"... Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV ..."
 
Vol 17, No 4 (2024) Development of a classification of anesthetic management methods and protocols for calculating financial costs Abstract  similar documents
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov
"... with providing anesthetic management, including labor costs for personnel directly involved in the medical ..."
 
Vol 15, No 3 (2022) Funding for coronavirus health worker payments Abstract  similar documents
I. Yu. Bocharova, A. Yu. Rymanov
 
Vol 13, No 4 (2020) Regional aspects for assessing the effectiveness of resources management in medical organizations Abstract  similar documents
О. A. Volkova, E. V. Smirnova, S. N. Cherkasov
"... characteristics of the medical care organization. Aim. To assess the effectiveness of personnel management ..."
 
Vol 5, No 1 (2012) MODERNIZATION OF THE MEDICAL SERVICES MARKET Abstract  similar documents
A. U. Kulikov
"... market. Identified non–price factors that affect consumer demand for medical services. Identified ..."
 
Vol 5, No 2 (2012) WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM Abstract  similar documents
A. I. Borodin
"... creation storekeeping of medicines is grouped by consumer properties, for each group demand is investigated ..."
 
Vol 10, No 1 (2017) THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva
"... используется стандартизованная методика расчета QALY, позволяющая применять данный показатель как универсальный ..."
 
Vol 13, No 2 (2020) Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
 
Vol 17, No 4 (2024) Standardized methodology for calculating the cost of medical care funded by government sources Abstract  similar documents
M. A. Sdvizhkova, S. A. Kovaleva, D. V. Fedyaev, V. V. Omelyanovskiy
"... стоимости МП – ключевой инструмент, влияющий на эффективность системы. Однако существующие методики расчета ..."
 
Vol 17, No 2 (2024) Approaches to determining the cost of laboratory tests Abstract  similar documents
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky
"... : провести обзор методов расчета себестоимости лабораторных исследований. Материал и методы. Исследование ..."
 
Vol 15, No 2 (2022) Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis Abstract  similar documents
O. S. Mikhaylova, A. V. Krikova
"... ,136 thousand in 2019. A growth in the number of cases resulted in an increase in the demand for drugs ..."
 
Vol 14, No 1 (2021) Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District Abstract  similar documents
M. S. Soboleva, E. E. Loskutova
"... 's rank correlation coefficient, Kruskal–Wallis test. Results. The maximum demand in patients among ..."
 
Vol 6, No 1 (2013) THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION Abstract  similar documents
A. Yu. Kulikov, Yu. L. Akimova
"... вакцинопрофилактики. Приведены критерии выбора показателей эффективности для различных типов вакцин, расчеты затрат на ..."
 
Vol 11, No 4 (2018) Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense Abstract  similar documents
D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy
"... of healthcare for the military and associated personnel. ..."
 
Vol 11, No 2 (2018) Current practice of organizing and financing the departmental healthcare system for the military in developed countries: a review Abstract  similar documents
T. P. Bezdenezhnykh, D. V. Lukyantseva
"... to the military personnel and the veterans. This report aims to review the current practice of organizing ..."
 
Vol 10, No 4 (2017) THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE Abstract  similar documents
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva
"... . Структура стандарта обеспечивает возможность расчета затрат на реализацию ПГГ, однако опыт работы над ..."
 
Vol 17, No 3 (2024) Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury Abstract  similar documents
M. O. Magomedaliev, D. I. Korabelnikov
"... dysfunction, the demand and duration of renal replacement therapy (RRT). The sCysC is an independent predictor ..."
 
Vol 13, No 3 (2020) Regulatory framework of the oncological medical care provision Abstract  similar documents
S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy
"... for medical organizations and resources’ demand assessment, including the need for financial support from ..."
 
Vol 10, No 4 (2017) PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... of patients from the “therapy on demand” to the standard and personalized preventive therapy was also ..."
 
Vol 6, No 3 (2013) THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT Abstract  similar documents
N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova
"...  there is a broad assortment, just a few medicines lead in the sales market and have a stabile demand. Federal ..."
 
Vol 17, No 2 (2024) Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy
"... помощи (МП) и необходимость единообразия расчетов потребовали выработки единого подхода к формированию ..."
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... в статье представлены результаты расчета необходимых финансовых затрат на лекарственное ..."
 
Vol 17, No 1 (2024) STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia Abstract  similar documents
A. V. Zhuravlev, O. I. Knysh
"... the capabilities of patients and MOs as well as the demand for drug therapy. Economic factors are based ..."
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
"... the reference to specialized departments; reduce the unnecessary “paper” work load on the medical personnel ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation Abstract  similar documents
A. Yu. Kulikov, L. A. Komarov
"... церебролизина для лечения ОНМК по ишемическому типу позволяет сэкономить примерно 1,47 млрд руб. в год в расчете ..."
 
Vol 8, No 4 (2015) HEALTHCARE SPENDING EFFICIENCY IN RUSSIAN REGIONS Abstract  similar documents
N. A. Avxentyev, V. M. Baydin, O. A. Zarubina, N. N. Sisigina, S. A. Kulkova
"... влияния внешних факторов; 3) расчет скорректированной оценки эффективности без учета влияния внешних ..."
 
Vol 7, No 2 (2014) THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID Abstract  similar documents
K. V. Danilova, I. M. Razdorskaya
"... концептуальный подход, включающий анализ производственного признака, стоимостной анализ, методика расчета ..."
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract  similar documents
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
"... медицинской помощи на примере расчета Программы государственных гарантий бесплатного оказания гражданам ..."
 
Vol 17, No 3 (2024) Review of open libraries for pharmacoeconomic analysis in R environment Abstract  similar documents
I. A. Lackman, R. I. Sladkov, V. M. Timiryanova
"... результатов и формирования отчетов, наличия виньеток и возможностей параллелизации расчетов. Результаты ..."
 
Vol 16, No 3 (2023) Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
"... . anaplastic lymphoma kinase, ALK) немелкоклеточным раком легкого (НМРЛ). Материал и методы. При расчетах ..."
 
Vol 12, No 4 (2019) Evolution of healthcare provider payment mechanisms Abstract  similar documents
V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina
"... the societal demands (greater access to health services, cost reduction, and better quality) and prevent “moral ..."
 
Vol 17, No 3 (2024) Artificial intelligence: basic terms and concepts, the application in healthcare and clinical medicine Abstract  similar documents
A. I. Lamotkin, D. I. Korabelnikov, I. A. Lamotkin
"... . It is important to consider the ethical aspects and the demand for further study of AI application in medicine ..."
 
Vol 16, No 2 (2023) Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice Abstract  similar documents
M. S. Soboleva
"... ” in pharmacy organizations and advanced personnel training.  ..."
 
Vol 13, No 4 (2020) The social-economic burden of spinal muscular atrophy in Russia Abstract  similar documents
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
"... ранее в РФ не рассчитывались. Цель. Расчет социо-экономического бремени СМА в РФ для все, популяции ..."
 
Vol 17, No 4 (2024) Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system Abstract  similar documents
A. V. Rudakova, I. Z. Gaydukova
"... ) BASDAI50. Временной горизонт исследования составил 2 года. При расчете учитывали только затраты на ..."
 
Vol 6, No 2 (2013) COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... полного цитогенетического ответа (ПЦО) на протяжении одного года из расчета на одного пациента с ХФ ХМЛ ..."
 
Vol 6, No 3 (2013) COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... добавленных лет жизни с качеством 100% (QALY). Из расчета лечения одного пациента, страдающего ХФ ХМЛ, на ..."
 
Vol 8, No 4 (2015) PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER Abstract  similar documents
D. A. Zhukov
"... (если необходимо)) и проведением процедуры Мараскуило. Расчеты выполнены в Microsoft Excel (прикладные ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... анализ влияния на бюджет. Расчеты проводились в модели, построенной в Microsoft Excel. В анализе «затраты ..."
 
Vol 10, No 1 (2017) EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS Abstract  similar documents
M. Yu. Frolov, V. A. Rogov
"... . Материалы и методы. Выполнен анализ влияния на бюджет (АВБ) и анализ «затраты-эффективность». Расчеты ..."
 
Vol 12, No 3 (2019) Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens Abstract  similar documents
D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko 
"... гарантий применяются ограниченно. Расчет подушевого норматива финансирования субъекта РФ зависит только от ..."
 
Vol 14, No 3 (2021) Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer Abstract  similar documents
Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova
"... –эффективность», а также расчет ресурсозатратности при применении нескольких вариантов химиотерапии мКРР: FOLFOX ..."
 
Vol 12, No 1 (2019) Effective search for potentially innovative scientific results in medicine Abstract  similar documents
M. B. Khrustalev, A. A. Maksimova
"... in low demand by Russian and foreign companies. Conclusion. Due to the low activity of medical ..."
 
Vol 12, No 3 (2019) Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics Abstract  PDF (Eng)  similar documents
S. V. Ponomarenko
"... in the Internet. The demand and supply in the market of recombinant therapeutic insulin, the insulin market ..."
 
Vol 16, No 4 (2023) Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market Abstract  similar documents
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova
"... demand in the pharmaceutical market retail segment included methotrexate, buserelin and anastrozole ..."
 
Vol 17, No 4 (2024) Scenario modeling of the drug prescription process for children: application of machine learning methods Abstract  similar documents
А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova
"... . The identified problems with predicting similar drugs validate the demand for further improvement of the model ..."
 
Vol 5, No 3 (2012) COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES Abstract  similar documents
M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova
"... жизни (КЖ), полученные на основании данных опросника Освестри, в дальнейшем использовались для расчета ..."
 
1 - 50 of 105 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)